XBiotech Inc. (XBIT)
USD 6.09
(-9.64%)
USD 6.09
(-9.64%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -18.72 Million | -14.82 Million | 69.44 Million | -65.14 Million | -18.27 Million | -16.53 Million |
| Net Income | -24.55 Million | -32.9 Million | -17.41 Million | -11.22 Million | 668.62 Million | -21.13 Million |
| Depreciation & Amortization | 1.74 Million | 2.61 Million | 2.64 Million | 2.23 Million | 2.36 Million | 2.43 Million |
| Deferred income taxes | -59 Thousand | -815 Thousand | -90 Thousand | -90 Thousand | -444 Thousand | - |
| Stock-based compensation | 3.26 Million | 5.06 Million | 4.46 Million | 12.58 Million | 3.35 Million | 1.66 Million |
| Change in working capital | 2.71 Million | 7.6 Million | 79.74 Million | -68.74 Million | -17.61 Million | 508 Thousand |
| Other non-cash items | -1.83 Million | 3.61 Million | 90 Thousand | 90 Thousand | -674.55 Million | 6.52 Million |
| Investing Cash Flow | 61.49 Million | -63.89 Million | -3.52 Million | -3.72 Million | 674.79 Million | -122 Thousand |
| Investments in PPE | -362 Thousand | -585 Thousand | -3.52 Million | -3.72 Million | -204 Thousand | -122 Thousand |
| Acquisitions | - | - | - | - | 675 Million | - |
| Investment purchases | - | -63.3 Million | - | - | - | - |
| Sales/Maturities of investments | 61.85 Million | - | - | - | - | - |
| Other Investing Activities | 61.85 Million | -63.3 Million | - | - | 675 Million | - |
| Financing Cash Flow | -9000.00 | - | -67 Million | -409.72 Million | 42.09 Million | 201 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | -75 Million | - | - | - |
| Common Stock Repurchased | - | - | - | -420 Million | - | - |
| Common Stock Issuance | 5000.00 | - | -420 Million | -420 Million | 38.06 Million | 201 Thousand |
| Other Financing Activities | -14 Thousand | - | 427.99 Million | 430.27 Million | 4.03 Million | 201 Thousand |
| Accounts receivables | 829 Thousand | 8.55 Million | 4.11 Million | -4.11 Million | - | - |
| Accounts payables | 91 Thousand | 357 Thousand | -514 Thousand | -334 Thousand | 496 Thousand | -78 Thousand |
| Inventory | - | -8.55 Million | -2.49 Million | -57.53 Million | - | - |
| Other working capital | 1.79 Million | 7.24 Million | 78.64 Million | -6.76 Million | -18.11 Million | 586 Thousand |
| Cash at beginning of period | 157.3 Million | 236.98 Million | 237.36 Million | 714.59 Million | 15.82 Million | 31.76 Million |
| Cash at end of period | 200.02 Million | 157.3 Million | 236.98 Million | 237.36 Million | 714.59 Million | 15.82 Million |
| Capital Expenditure | -362 Thousand | -585 Thousand | -3.52 Million | -3.72 Million | -204 Thousand | -122 Thousand |
| Effect of forex changes on cash | -46 Thousand | -961 Thousand | 705 Thousand | 1.37 Million | 149 Thousand | 513 Thousand |
| Net cash flow / Change in cash | 42.71 Million | -79.67 Million | -383 Thousand | -477.22 Million | 698.77 Million | -15.94 Million |
| Free Cash Flow | -19.08 Million | -15.4 Million | 65.92 Million | -68.87 Million | -18.47 Million | -16.65 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -13 Million | -10 Million | -24.55 Million | -4.63 Million | -7.36 Million | -8.74 Million |
| Depreciation & Amortization | 435 Thousand | 432 Thousand | 1.74 Million | 434 Thousand | 432 Thousand | 435 Thousand |
| Deferred income taxes | - | - | -59 Thousand | -128 Thousand | 1.88 Million | -1.2 Million |
| Stock-based compensation | 379 Thousand | 381 Thousand | 3.26 Million | 688 Thousand | 955 Thousand | 914 Thousand |
| Change in working capital | 262 Thousand | 405 Thousand | 2.71 Million | 1.32 Million | 3.42 Million | -276 Thousand |
| Other non-cash items | 2.67 Million | 2.82 Million | -1.83 Million | -1.11 Million | -824 Thousand | -127 Thousand |
| Investing Cash Flow | -627 Thousand | -255 Thousand | 61.49 Million | -115 Thousand | 61.82 Million | -208 Thousand |
| Investments in PPE | -627 Thousand | -255 Thousand | -362 Thousand | -115 Thousand | -33 Thousand | -208 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | 61.85 Million | - | - | - |
| Other Investing Activities | - | - | 61.85 Million | - | 61.85 Million | - |
| Financing Cash Flow | 48 Thousand | 10.05 Million | -9000.00 | -9.22 Million | 5000.00 | 9.2 Million |
| Debt repayment | - | -10 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 48 Thousand | 55 Thousand | 5000.00 | - | 5000.00 | - |
| Other Financing Activities | 48.00 | 10.05 Million | -14 Thousand | -9.22 Million | 5000.00 | 9.2 Million |
| Accounts receivables | -48 Thousand | -10 Thousand | 829 Thousand | 397 Thousand | 2.46 Million | -875 Thousand |
| Accounts payables | -825 Thousand | 8000.00 | 91 Thousand | 1.03 Million | -320 Thousand | 444 Thousand |
| Inventory | - | - | - | 1.00 | -2.46 Million | 875 Thousand |
| Other working capital | 1.13 Million | 407 Thousand | 1.79 Million | -101 Thousand | 3.74 Million | -720 Thousand |
| Cash at beginning of period | 201.03 Million | 200.02 Million | 157.3 Million | 202.19 Million | 143.39 Million | 152.48 Million |
| Cash at end of period | 188.53 Million | 201.03 Million | 200.02 Million | 200.02 Million | 202.19 Million | 143.39 Million |
| Capital Expenditure | -627 Thousand | -255 Thousand | -362 Thousand | -115 Thousand | -33 Thousand | -208 Thousand |
| Effect of forex changes on cash | -554 Thousand | -1.58 Million | -46 Thousand | 1.38 Million | -1.54 Million | 126 Thousand |
| Net cash flow / Change in cash | -12.5 Million | 1.01 Million | 42.71 Million | -2.16 Million | 58.8 Million | -9.09 Million |
| Free Cash Flow | -12 Million | -7.45 Million | -19.08 Million | -3.54 Million | -1.52 Million | -9.2 Million |
89988
KONMY
PREV
5240
RCF
6829